Wells Fargo
TRAW icon

Wells Fargo’s Traws Pharma TRAW Stock Holding History

Wells Fargo’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7
Closed -$166 – 7561
2024
Q1 		$166 Buy
7
+1
+17% +$19 ﹤0.01% 6538
2023
Q4 		$120 Hold
6
– – ﹤0.01% 6719
2023
Q3 		$109 Hold
6
– – ﹤0.01% 6749
2023
Q2 		$178 Hold
6
– – ﹤0.01% 6735
2023
Q1 		$106 Hold
6
– – ﹤0.01% 6924
2022
Q4 		$92 Hold
6
– – ﹤0.01% 6816
2022
Q3 		$0 Buy
6
+1
+20% +$30 ﹤0.01% 7510
2022
Q2 		$0 Hold
5
– – ﹤0.01% 7636
2022
Q1 		$0 Hold
5
– – ﹤0.01% 7962
2021
Q4 		$0 Buy
5
+1
+25% +$80 ﹤0.01% 7917
2021
Q3 		$0 Hold
4
– – ﹤0.01% 7624
2021
Q2 		$1K Hold
4
– – ﹤0.01% 6759
2021
Q1 		$2K Buy
4
+1
+33% +$377 ﹤0.01% 6651
2020
Q4 		$1K Hold
3
– – ﹤0.01% 6391
2020
Q3 		$0 Buy
3
+2
+200% +$494 ﹤0.01% 7014
2020
Q2 		$0 Hold
1
– – ﹤0.01% 6926
2020
Q1 		$0 Buy
+1
New +$157 ﹤0.01% 6912
2019
Q4 		– Sell
-299
Closed -$95K – 6807
2019
Q3 		$95K Buy
+299
New +$257K ﹤0.01% 5342
2019
Q2 		– Hold
0
– – – 6662
2019
Q1 		– Hold
0
– – – 6529
2018
Q4 		– Hold
0
– – – 6655
2018
Q3 		– Hold
0
– – – 6623
2014
Q4 		– Hold
0
– -$30K – 6455
2014
Q3 		– Hold
0
– – – 5131
2014
Q2 		– Hold
0
– – – 5081
2014
Q1 		– Sell
-5
Closed -$3.01M – 5480
2013
Q4 		$3.34M Buy
5
+1
+25% +$947K ﹤0.01% 2561
2013
Q3 		$6.3M Buy
+4
New +$5.72M ﹤0.01% 2021

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo's TRAW Position: Q2 2024 in Review

Wells Fargo sold out of Traws Pharma (TRAW) in Q2 2024, closing a stake of 7 shares — an estimated $166 sold.

Wells Fargo first reported a position in TRAW in Q3 2013 and held it in 20 quarters. The position peaked at $6.3M in Q3 2013. 28 funds tracked by Wall St. Rank hold TRAW as of Q2 2024.

  • Wells Fargo reported no remaining Traws Pharma position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 7 Traws Pharma shares in Q2 2024, an estimated $166.
  • Wells Fargo first reported a position in Traws Pharma in Q3 2013 and held it in 20 quarters.
  • Wells Fargo's Traws Pharma position peaked at $6.3M in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.